BC
BEAT

Brinker Capital’s BioTelemetry, Inc. BEAT Stock Holding History

Brinker Capital’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$994K Sell
22,007
-909
-4% -$40.7K 0.03% 501
2020
Q1 		$882K Buy
22,916
+2,534
+12% +$117K 0.04% 466
2019
Q4 		$944K Buy
20,382
+3,149
+18% +$136K 0.03% 528
2019
Q3 		$702K Buy
17,233
+60
+0.3% +$2.59K 0.02% 601
2019
Q2 		$827K Buy
17,173
+7,317
+74% +$385K 0.03% 540
2019
Q1 		$617K Buy
+9,856
New +$677K 0.02% 623

Other funds holding BEAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brinker Capital's BEAT Position: Q2 2020 in Review

Brinker Capital reduced its BioTelemetry, Inc. (BEAT) stake by 4% in Q2 2020, selling an estimated $40.7K and leaving 22,007 shares worth $994K. The position accounts for 0.03% of the portfolio, ranked #501.

Brinker Capital first reported a position in BEAT in Q1 2019 and has held it in 6 quarters since. 215 funds tracked by Wall St. Rank hold BEAT as of Q2 2020.

  • Brinker Capital held 22,007 shares of BioTelemetry, Inc. worth $994K as of Q2 2020.
  • Brinker Capital sold 909 BioTelemetry, Inc. shares in Q2 2020, an estimated $40.7K.
  • BioTelemetry, Inc. made up 0.03% of Brinker Capital's portfolio in Q2 2020, its #501 holding.
  • Brinker Capital first reported a position in BioTelemetry, Inc. in Q1 2019 and has held it in 6 quarters since.
  • 215 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.